(Q44425588)

2 December 2017

Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients (English)

1 reference

2 December 2017

1 reference

1 reference

Andreas Laras

1

1 reference

2 December 2017

John Koskinas

2

1 reference

2 December 2017

Evangelini Dimou

3

1 reference

2 December 2017

Ageliki Kostamena

4

1 reference

2 December 2017

Stephanos J Hadziyannis

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

2 December 2017

1 reference

2 December 2017

44

1 reference

2 December 2017

3

1 reference

2 December 2017

694-702

1 reference

Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) --> T, A(1762) --> T and G(1764) --> A mutations in the core promoter

2 December 2017

1 reference

Hepatitis B virus infection

21 January 2018

1 reference

7 January 2021

1 reference

7 January 2021

Hepatitis B virus replication--an update

1 reference

7 January 2021

Hepatitis B virus biology

1 reference

7 January 2021

Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate

1 reference

7 January 2021

Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell

1 reference

7 January 2021

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

1 reference

7 January 2021

The core promoter of hepatitis B virus

1 reference

7 January 2021

Hepatitis B virus (HBV) particles are produced in a cell culture system by transient expression of transfected HBV DNA.

1 reference

7 January 2021

In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway

1 reference

7 January 2021

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

1 reference

7 January 2021

Naturally occurring variants of hepatitis B virus

1 reference

7 January 2021

Clinical relevance of hepatitis B viral mutations

1 reference

7 January 2021

World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants

1 reference

7 January 2021

Hepatitis B e antigen-negative chronic hepatitis B.

1 reference

7 January 2021

Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication

1 reference

7 January 2021

In vivo suppression of precore mRNA synthesis is associated with mutations in the hepatitis B virus core promoter

1 reference

7 January 2021

Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

1 reference

7 January 2021

Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA.

1 reference

7 January 2021

Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro

1 reference

7 January 2021

Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants

1 reference

7 January 2021

A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus

1 reference

7 January 2021

A new and sensitive method for the quantification of HBV cccDNA by real-time PCR.

1 reference

7 January 2021

A quantitative method to detect HBV cccDNA by chimeric primer and real-time polymerase chain reaction.

1 reference

7 January 2021

Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR.

1 reference

7 January 2021

Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.

1 reference

7 January 2021

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

1 reference

7 January 2021

Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy

1 reference

7 January 2021

Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication

1 reference

7 January 2021

Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees

1 reference

7 January 2021

Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver

1 reference

7 January 2021

Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

Patterns of circulating hepatitis B virus serum nucleic acids during lamivudine therapy

1 reference

7 January 2021

Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification

1 reference

7 January 2021

Construction of avian hepadnavirus variants with enhanced replication and cytopathicity in primary hepatocytes

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21299

1 reference

2 December 2017

1 reference